Photo by GEORGE FREY/AFP via Getty Images
© 2024 Blaze Media LLC. All rights reserved.
France becomes first country to ban the use of hydroxychloroquine for treatment of COVID-19
May 27, 2020
Large studies are casting doubt on the controversial drug
The French government has banned the use of hydroxychloroquine to treat COVID-19, making France the first nation to do so since the start of the global pandemic.
The decision was passed down in a decree Wednesday morning by the Ministry of Solidarity and Health, which revoked previous authorization for the drug's use by doctors and in clinical trials.
"Whether [in doctors offices] in the cities or in the hospital, this ... should not be prescribed for patients with COVID-19," the ministry said in a statement following the decree, according to Politico.
The decision followed shortly after France's public health watchdog warned against using the drug and just two days after the World Health Organization announced it had suspended a global trial of the drug over safety concerns.
A study published last week in the Lancet also cast doubt on the efficacy of the drug. In the study, researchers were "unable to confirm a benefit" for the coronavirus patients and added that its use resulted in "decreased in-hospital survival and an increased frequency of ventricular arrhythmias."
Hydroxychloroquine, a widely used antimalarial drug often touted by President Donald Trump as a possible treatment for COVID-19, has been the subject of controversy since Trump had the U.S Food and Drug Administration fast-track it for use against the coronavirus in late March.
At the time, public health officials in the U.S. warned that evidence of the drug's effective was anecdotal at best.
While some patients and doctors around the country have reported the drug to be life-saving, large-scale clinical trials have yet to scientifically confirm the drug's effectiveness.
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
Phil Shiver
Phil Shiver is a former staff writer for The Blaze. He has a BA in History and an MA in Theology. He currently resides in Greenville, South Carolina. You can reach him on Twitter @kpshiver3.
more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.